Hyperbaric oxygen therapy (HBOT) has been FDA approved to treat numerous medical conditions. The FDA has continued to add new conditions as new scientific studies are being published proving that HBOT can be beneficial in numerous inflammatory conditions. At Rx-O2 Hyperbaric Clinic treatment is provided for on and off-label conditions under the guidance of the International Hyperbaric Association and the International Board of Underseas Medicine.
Hyperbaric oxygen is changing the field of medicine and according to a new study by The New England Journal of Medicine, HBOT has led to a 75% decrease in amputations in diabetic patients. Wound healing has been aided by HBOT due to the promotion of growth factors, increased blood vessel growth and the anti-inflammatory actions of oxygen under pressure. These same mechanisms are found to treat a number of other conditions.